Takhzyro

Takhzyro Indications/Uses

lanadelumab

Manufacturer:

Takeda

Distributor:

Zuellig

/

Firma Chun Cheong

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage Patient Counseling Information MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Indications/Uses

TAKHZYRO is indicated for routine prevention of recurrent attacks of hereditary angioedema (HAE) in patients aged 12 years and older.

Exclusive offer for doctors

Register for a MIMS account and receive free medical publications worth $768 a year.

Already a member? Sign in